BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37097039)

  • 1. Prognostic association of immunoproteasome expression in solid tumours is governed by the immediate immune environment.
    Kumar R; Dhaka B; Sahoo S; Jolly MK; Sabarinathan R
    Mol Oncol; 2023 Jun; 17(6):1041-1059. PubMed ID: 37097039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene signature of antigen processing and presentation machinery predicts response to checkpoint blockade in non-small cell lung cancer (NSCLC) and melanoma.
    Thompson JC; Davis C; Deshpande C; Hwang WT; Jeffries S; Huang A; Mitchell TC; Langer CJ; Albelda SM
    J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33028693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a cytokine-dominated immunosuppressive class in squamous cell lung carcinoma with implications for immunotherapy resistance.
    Yang M; Lin C; Wang Y; Chen K; Zhang H; Li W
    Genome Med; 2022 Jul; 14(1):72. PubMed ID: 35799269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sema4D correlates with tumour immune infiltration and is a prognostic biomarker in bladder cancer, renal clear cell carcinoma, melanoma and thymoma.
    Lu Q; Cai P; Yu Y; Liu Z; Chen G; Zeng Z
    Autoimmunity; 2021 Aug; 54(5):294-302. PubMed ID: 33974462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IP-score correlated to endogenous tumour antigen peptide processing: A candidate clinical response score algorithm of immune checkpoint inhibitors therapy in multiple cohorts.
    Wang Y; Yan K; Guo Y; Lu Y; Su H; Li H
    Front Immunol; 2022; 13():1085491. PubMed ID: 36700205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
    Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
    Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Programmed death ligand-1 (PD-L1) as a predictive marker for immunotherapy in solid tumours: a guide to immunohistochemistry implementation and interpretation.
    Paver EC; Cooper WA; Colebatch AJ; Ferguson PM; Hill SK; Lum T; Shin JS; O'Toole S; Anderson L; Scolyer RA; Gupta R
    Pathology; 2021 Feb; 53(2):141-156. PubMed ID: 33388161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KAT2B is an immune infiltration-associated biomarker predicting prognosis and response to immunotherapy in non-small cell lung cancer.
    Zhou X; Wang N; Zhang Y; Yu H; Wu Q
    Invest New Drugs; 2022 Feb; 40(1):43-57. PubMed ID: 34499335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clustering by antigen-presenting genes reveals immune landscapes and predicts response to checkpoint immunotherapy.
    Gong X; Karchin R
    Sci Rep; 2023 Jan; 13(1):950. PubMed ID: 36653470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of UBA6 by inosine augments tumour immunogenicity and responses.
    Zhang L; Jiang L; Yu L; Li Q; Tian X; He J; Zeng L; Yang Y; Wang C; Wei Y; Jiang X; Li J; Ge X; Gu Q; Li J; Wu D; Sadler AJ; Yu D; Xu D; Gao Y; Yuan X; He B
    Nat Commun; 2022 Sep; 13(1):5413. PubMed ID: 36109526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterizing heterogeneity of non-small cell lung tumour microenvironment to identify signature prognostic genes.
    Mi K; Chen F; Qian Z; Chen J; Lv D; Zhang C; Xu Y; Wang H; Zhang Y; Jiang Y; Shang D
    J Cell Mol Med; 2020 Dec; 24(24):14608-14618. PubMed ID: 33184998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of NOTCH4 mutation as a response biomarker for immune checkpoint inhibitor therapy.
    Long J; Wang D; Yang X; Wang A; Lin Y; Zheng M; Zhang H; Sang X; Wang H; Hu K; Zhao H
    BMC Med; 2021 Jul; 19(1):154. PubMed ID: 34284787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Hypoxia-Induced Carbonic Anhydrase IX Enhances Immune-Checkpoint Blockade Locally and Systemically.
    Chafe SC; McDonald PC; Saberi S; Nemirovsky O; Venkateswaran G; Burugu S; Gao D; Delaidelli A; Kyle AH; Baker JHE; Gillespie JA; Bashashati A; Minchinton AI; Zhou Y; Shah SP; Dedhar S
    Cancer Immunol Res; 2019 Jul; 7(7):1064-1078. PubMed ID: 31088846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infiltrating immune cells, but not tumour cells, express FasL in non-small cell lung cancer: No association with prognosis identified in 3-year follow-up.
    Toomey D; Smyth G; Condron C; Kelly J; Byrne AM; Kay E; Conroy RM; Broe P; Bouchier-Hayes D
    Int J Cancer; 2003 Jan; 103(3):408-12. PubMed ID: 12471625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune-Related Gene Expression Profiling After PD-1 Blockade in Non-Small Cell Lung Carcinoma, Head and Neck Squamous Cell Carcinoma, and Melanoma.
    Prat A; Navarro A; Paré L; Reguart N; Galván P; Pascual T; Martínez A; Nuciforo P; Comerma L; Alos L; Pardo N; Cedrés S; Fan C; Parker JS; Gaba L; Victoria I; Viñolas N; Vivancos A; Arance A; Felip E
    Cancer Res; 2017 Jul; 77(13):3540-3550. PubMed ID: 28487385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An immune gene expression signature distinguishes central nervous system metastases from primary tumours in non-small-cell lung cancer.
    Tsakonas G; Lewensohn R; Botling J; Ortiz-Villalon C; Micke P; Friesland S; Nord H; Lindskog M; Sandelin M; Hydbring P; Ekman S
    Eur J Cancer; 2020 Jun; 132():24-34. PubMed ID: 32325417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the immunoproteasome subunit β5i in non-small cell lung carcinomas.
    Kiuchi T; Tomaru U; Ishizu A; Imagawa M; Iwasaki S; Suzuki A; Otsuka N; Ohhara Y; Kinoshita I; Matsuno Y; Dosaka-Akita H; Kasahara M
    J Clin Pathol; 2021 May; 74(5):300-306. PubMed ID: 32943490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular, clinicopathological, and immune correlates of LAG3 promoter DNA methylation in melanoma.
    Fröhlich A; Sirokay J; Fietz S; Vogt TJ; Dietrich J; Zarbl R; Florin M; Kuster P; Saavedra G; Valladolid SR; Hoffmann F; Flatz L; Ring SS; Golletz C; Pietsch T; Strieth S; Brossart P; Gielen GH; Kristiansen G; Bootz F; Landsberg J; Dietrich D
    EBioMedicine; 2020 Sep; 59():102962. PubMed ID: 32861198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ICOS DNA methylation regulates melanoma cell-intrinsic ICOS expression, is associated with melanoma differentiation, prognosis, and predicts response to immune checkpoint blockade.
    Ralser DJ; Herr E; de Vos L; Kulcsár Z; Zarbl R; Klümper N; Gielen GH; Maas AP; Hoffmann F; Dietrich J; Kuster P; Mustea A; Glodde N; Kristiansen G; Strieth S; Landsberg J; Dietrich D
    Biomark Res; 2023 Jun; 11(1):56. PubMed ID: 37259155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.
    Zuo S; Wei M; Wang S; Dong J; Wei J
    Front Immunol; 2020; 11():1218. PubMed ID: 32714316
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.